Nrc Health earnings release, July 28, 2026

Nrc Health (NRC) · Form 8-K, Item 2.02 · Filed · SEC filing

NRC HEALTH ANNOUNCES SECOND QUARTER 2026 RESULTS

Second quarter TRCV* increased 11% year-over-year to $151.9 million

LINCOLN, Nebraska, July 28, 2026 — NRC Health (NASDAQ: NRC), a leader in healthcare experience improvement solutions, today announced results for the second quarter 2026.

"Our second quarter was a success on many fronts, including double-digit TRCV growth over the prior year, strong go-to-market and solutions delivery execution, continued commercialization of our product innovations, and the strongest bookings performance for The Governance Institute in seven years, positioning us well for a strong second half of 2026,” said Trent Green, CEO of NRC Health. “As healthcare organizations increasingly seek partners who can help improve experience outcomes, strengthen governance, and build enduring brand value, we believe NRC Health is uniquely differentiated through our three connected strengths: delivering continuous consumer and patient insights, providing trusted partnership and strategic engagement with healthcare leaders, and enabling actions that lead to improved outcomes.”

Second Quarter 2026 Highlights

* These financial measures are defined below under the headings

“

Non-GAAP Financial Measures” and

“

Total Recurring Contract Value.”

Reconciliations of the non-GAAP measures to their most closely comparable GAAP measures are included in the tables in this release.

Dividend Declaration

The Company’s Board of Directors on July 15, 2026, declared a quarterly cash dividend of $0.16 per share. The dividend will be payable on Friday, October 9, 2026, to shareholders of record as of the close of business on Friday, September 25, 2026.

© NRC Health

NRC Health Announces First Quarter 2026 Results

Page 2

July 28, 2026

Earnings Call Information

The company will be hosting a conference call to discuss the financial results on Tuesday, July 28, 2026, at 4:30 p.m. ET. A live webcast and replay of the call will be available on the NRC Health Investor Relations website at nrchealth.com/investor-relations.

About NRC Health

For more than 45 years, NRC Health (NASDAQ: NRC) has led the charge to humanize healthcare and support organizations in their understanding of each unique individual. NRC Health’s commitment to Human Understanding® helps leading healthcare systems get to know the patients, families, consumers, employees, and communities they serve on a human level. Guided by its uniquely empathic heritage, human-centered approach, unmatched national market research, and emphasis on consumer preferences, NRC Health is transforming the healthcare experience, creating strong outcomes across the healthcare journey. For more information, email info@nrchealth.com, or visit www.nrchealth.com.

Total Recurring Contract Value

Total Recurring Contract Value, or TRCV, is viewed by management as a leading indicator of our future revenue trends. It represents the total annualized contract value under customer contracts that are in effect or contractually committed as of the most recent quarter-end, based on contractual pricing and term provisions, and expected to be in force over the subsequent 12 months. TRCV is an operating metric and is not a measure of revenue recognized under U.S. GAAP.

Non-GAAP Financial Measures

In addition to consolidated GAAP financial measures, NRC Health reviews various non-GAAP financial measures that management believes to be important in the evaluation of its operating results and performance, including “Adjusted Net Income,” “Adjusted Earnings per Share,” “Adjusted EBITDA,” “Adjusted EBITDA Margin,” “Free Cash Flow,” and “Free Cash Flow Margin.” Reconciliations of GAAP to non-GAAP financial information are provided later in this release.

NRC Health believes Adjusted Net Income, Adjusted Earnings per Share, Adjusted EBITDA, and Adjusted EBITDA Margin are helpful supplemental measures to assist management and investors in evaluating the Company’s operating results as (i) they exclude certain items that are unusual in nature or whose fluctuation from period to period do not necessarily correspond to changes in the operations of NRC Health’s business, and (ii) the exclusion of non-cash stock compensation is useful for investors applying certain valuation metrics and is consistent with the leverage ratio for our credit facility.

Adjusted Net Income represents net income adjusted to add back management transition costs and non-cash stock compensation and the related tax. The income tax effect on non-GAAP adjustments is calculated by applying the Company's blended federal and state statutory rate to the deductible portion of each adjustment; amounts nondeductible under Section 162(m) of the Internal Revenue Code receive no tax effect. Adjusted EBITDA represents net income before interest, taxes, depreciation, amortization, management transition costs, and non-cash stock compensation items. Adjusted EBITDA Margin represents Adjusted EBITDA divided by our revenue.

© NRC Health

NRC Health Announces First Quarter 2026 Results

Page 3

July 28, 2026... (truncated)in connection with amendments to their 2025 equity awards, as previously disclosed, and approximately $270,000 of severance costs incurred in connection with team restructurings implemented by newly appointed executives.

NRC Health considers Free Cash Flow to be a measure that provides useful information to management and investors about our liquidity. Free Cash Flow does not represent residual cash flow available for discretionary expenditures. We define Free Cash Flow as net cash provided by operating activities less capital expenditures. Free Cash Flow Margin represents Free Cash Flow divided by our revenue.

There is no comprehensive, authoritative guidance for the presentation of such non-GAAP information, which is only meant to supplement GAAP results by providing additional information that management utilizes to assess performance.

Financial statements

Income Statement

Three months ended June 30, — (In thousands except per share data, unaudited)

Three months ended June 30, – 2026Three months ended June 30, – 2025Six months ended June 30, – 2026Six months ended June 30, – 2025
Revenue35,39234,03870,19567,588
Operating expenses:Direct13,56412,97427,21026,031
Operating expenses:Selling, general, and administrative22,94517,73436,36428,089
Operating expenses:Depreciation and amortization2,1211,7424,2903,284
Operating expenses:Total operating expenses38,63032,45067,86457,404
Operating expenses:Operating income (loss)-3,2381,5882,33110,184
Other income (expense):Interest income20215541
Other income (expense):Interest expense-1,321-1,032-2,576-1,932
Other income (expense):Other, net243211
Other income (expense):Total other expense-1,299-1,007-2,489-1,880
Other income (expense):Income (loss) before income taxes-4,537581-1588,304
Other income (expense):Provision for income taxes-1,254687-972,623
Other income (expense):Net income (loss)-3,283-106-615,681
Earnings (loss) per share of common stock:Basic-0.15-0.01-0.010.25
Earnings (loss) per share of common stock:Diluted-0.15-0.01-0.010.25
Weighted average shares and share equivalents outstanding:Basic22,00922,65821,90522,814
Weighted average shares and share equivalents outstanding:Diluted22,00922,65821,90522,820

Income Statement

Three months ended June 30, — Adjusted Net Income and Adjusted Earnings per Share (in thousands)

Three months ended June 30, – 2026Three months ended June 30, – 2025Six months ended June 30, – 2026Six months ended June 30, – 2025
Net income (loss)-3,283-106-615,681
Add back:Management transition costs13,1606,6403,1606,640
Add back:Tax on management transition costs 2-180-468-180-468
Add back:Non-cash stock compensation7,3713078,979478
Add back:Tax on non-cash stock compensation 2-21022-470-21
Add back:Adjusted net income6,8586,39511,42812,310
Add back:Earnings (loss) per share of common stock, diluted-0.15-0.01-0.010.25
Add back:Weighted average shares and share equivalents outstanding, diluted22,00922,65821,90522,820
Add back:Adjusted earnings per share of common stock, diluted0.310.280.520.54
Add back:Adjusted weighted average shares and share equivalents outstanding, diluted22,11322,66122,04922,820

Income Statement

Three months ended June 30, — Adjusted EBITDA and Adjusted EBITDA Margin

Three months ended June 30, – 2026Three months ended June 30, – 2025Six months ended June 30, – 2026Six months ended June 30, – 2025
Net income (loss)-3,283-106-615,681
Add back:Depreciation and amortization2,1211,7424,2903,284
Add back:Interest expense1,3211,0322,5761,931
Add back:Income taxes-1,254687-972,623
Add back:Management transition costs13,1606,6403,1606,640
Add back:Non-cash stock compensation7,3713078,979478
Add back:Adjusted EBITDA9,43610,30218,84720,637
Add back:Net income (loss) margin-9.0%8
Add back:Adjusted EBITDA margin27.0%30.0%27.0%31

Balance Sheet

June 30, 2026 — (Dollars in thousands except share amounts and par value)

June 30, 2026 – (unaudited)December 31, 2025
Current assets:Cash and cash equivalents3,3274,139
Current assets:Accounts receivable, net9,32411,108
Current assets:Other current assets10,1554,962
Current assets:Total current assets22,80620,209
Current assets:Property and equipment, net39,49740,474
Current assets:Goodwill66,15266,152
Current assets:Other, net7,6978,043
Current assets:Total assets136,152134,878
Current liabilities:Current portion of notes payable, net of unamortized debt issuance costs4,0164,014
Current liabilities:Accounts payable and accrued expenses4,9904,066
Current liabilities:Accrued wages and bonuses5,3557,218
Current liabilities:Deferred revenue16,71616,201
Current liabilities:Dividends payable3,5423,625
Current liabilities:Other current liabilities4001,496
Current liabilities:Total current liabilities35,01936,620
Current liabilities:Notes payable, net of current portion and unamortized debt issuance costs86,01275,021
Current liabilities:Other non-current liabilities8,5729,247
Current liabilities:Total liabilities129,603120,888
Shareholders’ equity:Common stock, $0.001 par value; authorized 110,000,000 shares, issued 31,975,649 in 2026 and 31,966,504 in 2025, outstanding 22,139,315 in 2026 and 22,637,252 in 20253232
Shareholders’ equity:Additional paid-in capital192,998183,880
Shareholders’ equity:Retained earnings (accumulated deficit)-24,507-17,298
Shareholders’ equity:Treasury stock-161,974-152,624
Shareholders’ equity:Total shareholders’ equity6,54913,990
Shareholders’ equity:Total liabilities and shareholders’ equity136,152134,878

Cash Flow

Three months ended June 30, — (In thousands, unaudited) (in thousands)

Three months ended June 30, – 2026Three months ended June 30, – 2025Six months ended June 30, – 2026Six months ended June 30, – 2025
Cash flows from operating activities:Net income-3,283-106-615,681
Adjustments to reconcile net income to net cash provided by operating activities:Depreciation and amortization2,1211,7424,2903,284

Cash Flow

Three months ended June 30, — Free Cash Flow and Free Cash Flow Margin

Three months ended June 30, – 2026Three months ended June 30, – 2025Six months ended June 30, – 2026Six months ended June 30, – 2025
Net cash provided by (used in) operating activities1,386-1,1398,5665,507
Less:Capital expenditures1,3243,0103,1585,996
Less:Free cash flow62-4,1495,408-489
Less:Net cash provided by operating activities margin4.0%-3.0%12.0%8.0%
Less:Free cash flow margin-12.0%8.0%-1.0%
Full release

Forward-Looking Statements

This press release contains certain statements that may be considered forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and such statements are subject to the safe harbor created by those sections and the Private Securities Litigation Reform Act of 1995, as amended. Such statements may be identified by their use of terms or phrases such as “believes,” “expect,” “focus,” “potential,” “will,” derivations thereof, and similar terms and phrases. Forward-looking statements are based upon the current beliefs and expectations of our management and are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified, which could cause future events and actual results to differ materially from those set forth in, contemplated by, or underlying the forward-looking statements, including those risks and uncertainties as set forth in the Risk Factors section of our Annual Report on Form 10-K for the year ended December 31, 2025, and various disclosures in our press releases, stockholder reports, and other filings with the Securities and Exchange Commission. We disclaim any obligation to update or revise any forward-looking statements to reflect actual results or changes in the factors affecting the forward-looking information.

Media Contact marketing@nrchealth.com

Investor Contact ir@nrchealth.com

© NRC Health

NRC Health Announces First Quarter 2026 Results

Page 4

July 28, 2026

NRC HEALTH

Condensed Consolidated Statements of Income

(In thousands except per share data, unaudited)

© NRC Health

NRC Health Announces First Quarter 2026 Results

Page 5

July 28, 2026

NRC HEALTH

Condensed Consolidated Balance Sheets

(Dollars in thousands except share amounts and par value)

© NRC Health

NRC Health Announces First Quarter 2026 Results

Page 6

July 28, 2026

NRC HEALTH

Condensed Consolidated Statements of Cash Flows

(In thousands, unaudited)

© NRC Health

NRC Health Announces First Quarter 2026 Results

Page 7

July 28, 2026

NRC HEALTH

Reconciliation of GAAP to Non-GAAP Financial Measures

(In thousands, except per share data, unaudited)

Adjusted Net Income and Adjusted Earnings per Share

© NRC Health

NRC Health Announces First Quarter 2026 Results

Page 8

July 28, 2026

Adjusted EBITDA and Adjusted EBITDA Margin

Free Cash Flow and Free Cash Flow Margin

© NRC Health

From SEC EDGAR. Analysis by Pear Digitals from the filing alone. Not investment advice. · Nrc Health earnings · Latest earnings · Markdown

Screener

Plans

Premium and Pro coming soon.

Log in

New here?

Join the waitlist

Pear FMV opens to everyone soon. We'll email you when it does.